Cart Icon0
Menu

Search from website

Recombinant mAb to human MANF (clone 2B8, chicken-mouse IgG2a chimeric antibody)

               

Figure 1. IF testing of anti-MANF monoclonal antibody (341-100). Immunofluorescence detection of human MANF expressed in human U2OS cells by chimeric monoclonal  antibody to hMANF (341-100). Anti-hMANF antibody dilution in IF experiment was 1 µg/ml. Upper panel: MANF-expressing U2OS cells. Lower panel: Negative control (non-transfected cells)

   

A

             

B

             

Figure 2: Immunohistochemical analysis of MANF monoclonal antibody (341-100). Analysis was performed using mouse pancreas cryosections. Antibody concentration of 5 µg/ml was used. A. WT mouse pancreas. B. MANF KO mouse pancreas.

Select volume:

Quantity:

Catalogue #

341-100

Name

Recombinant mAb to human MANF (clone 2B8, chicken-mouse IgG2a chimeric antibody)

Target

Human MANF

Target Description

Recombinant human MANF protein produced using CHO-based Icosagen Cell factory Ltd. proprietary suspension cell line. Immunogen is purified from cell culture supernatant

Alternative Names

ARMET, ARP, mesencephalic astrocyte-derived neurotrophic factor

Uniprot ID

P55145

Clonality

Mouse monoclonal

Clone

2B8, chicken-mouse IgG2a chimeric antibody

Class

mIgG2a

Reactivity

Human MANF

Application

ELISA, IF

Protocol

Conformational antibody, not suitable for Western Blot application.

Monoclonal antibody working titer has to be established practically for each particular antigen and assay format

ELISA:

0,02-0,1 µg/ml

WB:

Conformational antibody, not suitable for Western Blot application

IF:

1-20 µg/ml

Purification

Protein A affinity chromatography

Buffer

PBS pH 7.4, with 0.1% sodium azide

Shipping

Shipping in ambient conditions.

Storage

Store at -20 °C to -70 °C. Avoid multiple freeze-thaw cycles.

Background

MANF is a trophic factor for midbrain dopamine neurons in vivo. It prevents the 6-OHDA- induced degeneration of dopamine neurons in rodent models of Parkinson’s disease (Lindholm et al., 2008, Voutilainen et al., 2009). When administered after 6-OHDA-lesioning it restores the dopaminergic function and prevents degeneration of dopamine neurons in substantia nigra pars compacta.

This product is for research use only

TECHNICAL ASSISTANCE

Please refer any technical questions to

technical.support@icosagen.com

Our locations

United States Office

77 Geary St. 5th Floor
San Francisco, CA 94108

European Office

Eerika tee 1
Õssu, Kambja vald
Tartu maakond 61713
Estonia
+372 737 7070
Shopping Cart